DOCSLIB.ORG

List of Autoimmune Diseases

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Crohn’s disease H Hashimoto’s thyroiditis (also known Landry’s paralysis (also known as Crow-Fukase syndrome (also as chronic lymphocytic thyroiditis) Miller Fisher syndrome and Guillain- known as Takatsuki disease, PEP Hashimoto’s encephalitis or Barré syndrome) syndrome, and POEMS syndrome) encephalopathy Leukocytoclastic vasculitis Henoch-Schönlein purpura (also Lichen planus (CFA; also known as idiopathic known as anaphylactoid purpura Lichen sclerosus and purpura rheumatica) Ligneous conjunctivitis alveolitis) Herpes gestationis (also known as Limited systemic sclerosis (also Demyelinating neuropathies (also gestational pemphigoid) D known as limited systemic Horton disease (also known as giant scleroderma and CREST syndrome) demyelinating diseases) cell arteritis, temporal arteritis, and Linear IgA disease (LAD; also Dermatomyositis (DM) cranial arteritis) known as adult linear IgA disease) Devic’s disease (also known as Hughes syndrome (also known as Lupus (also known as systemic neuromyelitis optica) antiphospholipid syndrome) lupus erythematosus) Diabetes mellitus type 1 (also known Hypocortisolism (also known as Lyme disease, chronic as insulin-dependent diabetes and hypoadrenalism, Addison’s disease, type 1 diabetes) Lymph node syndrome (also known as mucocutaneous lymph node Discoid lupus erythematosus (DLE) Hypogammaglobulinemia syndrome and Kawasaki disease) Dressler’s syndrome (also known as Lymphoid hamartoma (also known postmyocardial infarction syndrome) I disease (includes both Crohn’s as angiofollicular lymph node disease and ulcerative colitis) Duhring’s disease (also known as hyperplasia, Castleman’s disease, dermatitis herpetiformis) and giant lymph node hyperplasia) demyelinating diseases (also known Endocarditis lenta (also known as Marchiafava-Micheli syndrome (also as demyelinating neuropathies) E subacute bacterial endocarditis) M known as paroxysmal nocturnal Endometriosis hemoglobinuria) Eosinophilic esophagitis or Marie-Strümpell disease (also gastroenteritis known as ankylosing spondylitis Idiopathic thrombocytopenic Eosinophilic fasciitis and Bekhterev’s disease) purpura (ITP; also known as Ménière’s disease Erythema nodosum thrombocytopenic purpura and Erythroblastopenia (also known as autoimmune thrombocytopenic Microscopic polyangiitis (also pure red cell aplasia) purpura) known as microscopic polyarteritis) Essential mixed cryoglobulinemia IgA nephropathy (also known as Miller Fisher syndrome (also known as Guillain-Barré syndrome and Evans syndrome synpharyngitic glomerulonephritis and Berger’s disease) Landry’s paralysis) Experimental allergic Mixed connective tissue disease encephalomyelitis (EAE) IgG4-related sclerosing disease (MCTD; also known as Sharp’s Inclusion body myositis Fibrosingalveolitis (also known as syndrome) F Insulin-dependent diabetes (also Moersch-Woltman condition (also known as type 1 diabetes and known as stiff person syndrome) Gestational pemphigoid (also known diabetes mellitus type 1) Mooren’s ulcer G as herpes gestationis) Interstitial cystitis (also known as Mucha-Habermann disease Giant cell arteritis (also known as bladder pain syndrome) (also known as acute guttate temporal arteritis, cranial arteritis, Juvenile diabetes (also known as parapsoriasis, acute parapsoriasis, and Horton disease) J diabetes mellitus type 1, insulin- acute pityriasis lichenoides, dependent diabetes, and type 1 Giant lymph node hyperplasia (also and parapsoriasis or pityriasis diabetes) known as lymphoid hamartoma, lichenoides et varioliformis acuta) angiofollicular lymph node Juvenile rheumatoid arthritis (also Mucocutaneous lymph node hyperplasia, and Castleman’s known as juvenile idiopathic arthritis syndrome (also known as lymph disease) and Still’s disease) node syndrome and Kawasaki Glomerulonephritis Kawasaki syndrome (also known disease) K as Kawasaki disease, lymph node Goodpasture’s syndrome Multiple sclerosis syndrome, and mucocutaneous Granulomatosis with polyangiitis lymph node syndrome) Myasthenia gravis (GPA; also known as Wegener’s Myositis granulomatosis) Kussmaul-Maier disease (also known as polyarteritis nodosa) Narcolepsy Graves’ disease N Lambert-Eaton syndrome Neuromyelitis optica (also known as Guillain-Barré syndrome (also L (also known as Lambert-Eaton Devic’s disease) known as Landry’s paralysis and myasthenic syndrome) Miller Fisher syndrome) Neutropenia 2 Ocular cicatricial pemphigoid Progressive hemifacial atrophy Stiff person syndrome (also known O (also known as benign mucous (also known as Parry Romberg as Moersch-Woltman condition) membrane pemphigoid and scarring syndrome) Still’s disease (also known as pemphigoid) Psoriasis juvenile rheumatoid arthritis and Optic neuritis Psoriatic arthritis (also known as juvenile idiopathic arthritis) Ord’s thyroiditis arthritis psoriatica and arthropathic Subacute bacterial endocarditis Ormond’s disease (also known as psoriasis) (SBE; also known as endocarditis Pure red cell aplasia (also known as lenta) Palindromic rheumatism erythroblastopenia) Susac’s syndrome (also known as P retinocochleocerebral vasculopathy) Paraneoplastic cerebellar Purpura rheumatic (also known as degeneration Henoch-Schönlein purpura and Sydenham’s chorea (also known as anaphylactoid purpura) chorea minor) Parapsoriasis varioliformis (also known as Mucha-Habermann Pyoderma gangrenosum Sympathetic ophthalmia (SO) disease acute guttate parapsoriasis, Rasmussen’s encephalitis (also Synpharyngitic glomerulonephritis acute parapsoriasis, acute pityriasis R known as chronic focal encephalitis) (also known as Berger’s disease lichenoides, parapsoriasis or Raynaud’s phenomenon, disease, and IgA nephropathy) pityriasis lichenoides et varioliformis or syndrome Systemic chondromalacia (also acuta) Reactive arthritis (also known as known as relapsing polychondritis Paroxysmal nocturnal Reiter’s syndrome) and atrophic polychondritis) hemoglobinuria (PNH; also known Systemic lupus erythematosus as Marchiafava-Micheli syndrome) (SLE; also known as lupus) Reiter’s syndrome (also known as Parry-Romberg syndrome (also reactive arthritis) Takatsuki disease (also known as known as progressive hemifacial T PEP syndrome, POEMS syndrome, Relapsing polychondritis (also atrophy) and Crow-Fukase syndrome) known as atrophic polychondritis Pars planitis (also known as and systemic chondromalacia) Takayasu’s arteritis or disease peripheral uveitis) Restless legs syndrome (also known Temporal arteritis (also known as Parsonage-Turner syndrome as Willis-Ekbom disease) giant cell arteritis, cranial arteritis, (also known as acute brachial and Horton disease) neuropathy, acute brachial Retinocochleocerebral vasculopathy Thrombocytopenic purpura radiculitis, neuralgic amyotrophy, (also known as Susac’s syndrome) (TTP; also known as idiopathic brachial neuritis, brachial plexus thrombocytopenic purpura and neuropathy, and brachial plexitis) as Ormond’s disease) autoimmune thrombocytopenic Pediatric autoimmune Rheumatic fever purpura) neuropsychiatric disorders Rheumatoid arthritis Tolosa-Hunt syndrome associated with streptococcus (PANDAS) Sarcoidosis (also known as Besnier- Transverse myelitis S Boeck disease) Pemphigus vulgaris Type I diabetes (also known as Scarring pemphigoid (also known diabetes mellitus type 1 and insulin- PEP syndrome (also known as as ocular cicatricial pemphigoid dependent diabetes) POEMS syndrome, Crow-Fukase and benign mucous membrane Types 1, 2, and 3 autoimmune syndrome, and Takatsuki disease) pemphigoid) polyglandular syndrome Peripheral neuropathy (also Schmidt’s syndrome (also known Ulcerative colitis known as autoimmune peripheral as autoimmune polyendocrine U neuropathy) syndrome type 2) Undifferentiated connective tissue disease (UCTD) Perivenous encephalomyelitis Schnitzler syndrome Urticarial vasculitis (also known as Pernicious anemia Scleritis chronic urticaria as a manifestation POEMS syndrome (also known as Scleroderma of venulitis) Crow-Fukase syndrome, Takatsuki disease, and PEP syndrome) Sharp’s syndrome (also known as Uveitis (also known as autoimmune mixed connective tissue disease) uveitis) Polyarteritis nodosa (also known as Kussmaul-Maier disease) Sicca syndrome (also known as Vasculitis Sjögren’s syndrome) V Polymyalgia rheumatica Vesiculobullous dermatosis Silk Road disease (also known as Vitiligo Polymyositis (PM) Behçet’s disease) Wegener’s granulomatosis (also Postmyocardial infarction syndrome Sjögren’s syndrome (also known as W known as granulomatosis with (also known as Dressler’s syndrome) Sicca syndrome) polyangiitis) Postpericardiotomy syndrome Sperm and testicular autoimmunity Willis-Ekbom disease (also known Primary biliary cirrhosis (PBC) Spot baldness (also known as as restless leg syndrome) Primary sclerosing cholangitis (PSC) alopecia areata) 3.
Recommended publications
  • ANCA--Associated Small-Vessel Vasculitis

    ANCA--Associated Small-Vessel Vasculitis

    ANCA–Associated Small-Vessel Vasculitis ISHAK A. MANSI, M.D., PH.D., ADRIANA OPRAN, M.D., and FRED ROSNER, M.D. Mount Sinai Services at Queens Hospital Center, Jamaica, New York and the Mount Sinai School of Medicine, New York, New York Antineutrophil cytoplasmic antibodies (ANCA)–associated vasculitis is the most common primary sys- temic small-vessel vasculitis to occur in adults. Although the etiology is not always known, the inci- dence of vasculitis is increasing, and the diagnosis and management of patients may be challenging because of its relative infrequency, changing nomenclature, and variability of clinical expression. Advances in clinical management have been achieved during the past few years, and many ongoing studies are pending. Vasculitis may affect the large, medium, or small blood vessels. Small-vessel vas- culitis may be further classified as ANCA-associated or non-ANCA–associated vasculitis. ANCA–asso- ciated small-vessel vasculitis includes microscopic polyangiitis, Wegener’s granulomatosis, Churg- Strauss syndrome, and drug-induced vasculitis. Better definition criteria and advancement in the technologies make these diagnoses increasingly common. Features that may aid in defining the spe- cific type of vasculitic disorder include the type of organ involvement, presence and type of ANCA (myeloperoxidase–ANCA or proteinase 3–ANCA), presence of serum cryoglobulins, and the presence of evidence for granulomatous inflammation. Family physicians should be familiar with this group of vasculitic disorders to reach a prompt diagnosis and initiate treatment to prevent end-organ dam- age. Treatment usually includes corticosteroid and immunosuppressive therapy. (Am Fam Physician 2002;65:1615-20. Copyright© 2002 American Academy of Family Physicians.) asculitis is a process caused These antibodies can be detected with indi- by inflammation of blood rect immunofluorescence microscopy.
  • A Review of Primary Vasculitis Mimickers Based on the Chapel Hill Consensus Classification

    A Review of Primary Vasculitis Mimickers Based on the Chapel Hill Consensus Classification

    Hindawi International Journal of Rheumatology Volume 2020, Article ID 8392542, 11 pages https://doi.org/10.1155/2020/8392542 Review Article A Review of Primary Vasculitis Mimickers Based on the Chapel Hill Consensus Classification Farah Zarka ,1 Charles Veillette ,1 and Jean-Paul Makhzoum 2 1Hôpital du Sacré-Cœur de Montreal, University of Montreal, Canada 2Vasculitis Clinic, Department of Internal Medicine, Hôpital du Sacré-Coeur de Montreal, University of Montreal, Canada Correspondence should be addressed to Jean-Paul Makhzoum; [email protected] Received 10 July 2019; Accepted 7 January 2020; Published 18 February 2020 Academic Editor: Charles J. Malemud Copyright © 2020 Farah Zarka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Primary systemic vasculitides are rare diseases that may manifest similarly to more commonly encountered conditions. Depending on the size of the vessel affected (large vessel, medium vessel, or small vessel), different vasculitis mimics must be considered. Establishing the right diagnosis of a vasculitis mimic will prevent unnecessary immunosuppressive therapy. 1. Introduction 2. Large-Vessel Vasculitis Mimics Vasculitides are rare heterogenous diseases that affect vessel Large-vessel vasculitis (LVV) is an inflammatory vascu- walls as the main site of inflammation. Organs affected vary lopathy affecting large arteries; giant cell arteritis (GCA) depending on the type and size of blood vessels involved and Takayasu’s arteritis (TAK) are the two main docu- [1]. Autoimmune vasculitis can be primary (idiopathic) or mented variants, each with their own characteristic fea- secondary to an underlying disease.
  • Rheumatology 2 Objectives

    Rheumatology 2 Objectives

    1 RHEUMATOLOGY 2 OBJECTIVES Know and understand: • How the clinical presentations of rheumatologic diseases can vary • Components of a thorough physical examination for investigating rheumatoid complaints • How to differentiate between different rheumatologic diseases • Evidence-based management of rheumatologic diseases 3 TOPICS COVERED • Osteoarthritis • Rheumatoid Arthritis • Gout • Calcium Pyrophosphate Deposition Disease • Polymyalgia Rheumatica • Giant Cell Arteritis (Temporal Arteritis) • Systemic Lupus Erythematosus • Sjögren Syndrome • Polymyositis and Dermatomyositis • Fibromyalgia 4 OSTEOARTHRITIS (OA): OVERVIEW • Principal cause of knee, hip, and back pain in older adults, and most common source of chronic pain • Avoid the reflexive conclusion that all joint pain in older adults is the result of OA • Can develop in any joint that has suffered injury or other disease • Hallmark: cartilage degeneration Ø But not purely a degenerative disease; subchondral bone abnormalities and focal synovial inflammation are also seen in pathologic specimens 5 OA: DIAGNOSIS • Differential diagnosis: inflammatory and crystal arthritides, septic arthritis, bone pain due to malignancy • Bony enlargement and crepitus suggest OA Ø In the fingers, bony enlargement occurs in the distal interphalangeal joint (Heberden nodes) and in the proximal interphalangeal joints (Bouchard nodes) Ø Osteophytes are the radiographic counterpart of this enlargement, and asymmetric joint space narrowing is common • Joint tenderness and warmth may appear, but true synovitis
  • Guideline-Management-Giant-Cell

    Guideline-Management-Giant-Cell

    Arthritis Care & Research Vol. 73, No. 8, August 2021, pp 1071–1087 DOI 10.1002/acr.24632 © 2021 American College of Rheumatology. This article has been contributed to by US Government employees and their work is in the public domain in the USA. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis Mehrdad Maz,1 Sharon A. Chung,2 Andy Abril,3 Carol A. Langford,4 Mark Gorelik,5 Gordon Guyatt,6 Amy M. Archer,7 Doyt L. Conn,8 Kathy A. Full,9 Peter C. Grayson,10 Maria F. Ibarra,11 Lisa F. Imundo,5 Susan Kim,2 Peter A. Merkel,12 Rennie L. Rhee,12 Philip Seo,13 John H. Stone,14 Sangeeta Sule,15 Robert P. Sundel,16 Omar I. Vitobaldi,17 Ann Warner,18 Kevin Byram,19 Anisha B. Dua,7 Nedaa Husainat,20 Karen E. James,21 Mohamad A. Kalot,22 Yih Chang Lin,23 Jason M. Springer,1 Marat Turgunbaev,24 Alexandra Villa-Forte, 4 Amy S. Turner,24 and Reem A. Mustafa25 Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particu- lar patient. The ACR considers adherence to the recommendations within this guideline to be voluntary, with the ultimate determination regarding their application to be made by the physician in light of each patient’s individual circumstances. Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome.
  • PMR) / Giant Cell Arteritis (GCA

    PMR) / Giant Cell Arteritis (GCA

    Arthritis and Rheumatology Clinics of Kansas Patient Education Polymyalgic Rheumatica (PMR) / Giant Cell Arteritis (GCA) Introduction: PMR and GCA are related conditions affecting adults over the age of 50. Both are inflammatory diseases, with PMR involving the large joints of the hips and/or shoulders and GCA involving large and medium sized blood vessels. PMR occurs in about 30 individuals over the age of 50 per 100,000 population per year, while GCA is roughly half as common. Both conditions are about twice as common in women as in men and are seen most commonly in those of Northern European descent. The average age of onset is about 70 for both conditions, and with the aging population the prevalence of these disorders is expected to increase in the next few decades. While the cause of these conditions is unknown, the fact that they tend to occur in cooler climates and in clusters of cases every several years suggests that infections may trigger PMR and GCA. Having certain genes also seems to increase the risk of developing either of these disorders. Features of PMR: Patients with PMR tend to experience widespread pain in the regions of the shoulders, upper arms, neck, hips, buttock, and thighs. These symptoms may be sudden in onset and are accompanied by up to several hours of morning stiffness. While swelling of knees, elbows, or wrists may occur, there is most often no visible joint swelling but only difficulty with movement of the larger joints. A small percentage of patients may experience swelling of the entire hand and foot with edema, or excess fluid accumulation.
  • Blistering, Papulosquamous, Connective Tissue and Alopecia Kathleen Haycraft, DNP, FNP/PNP-BC, DCNP, FAANP Objectives

    Blistering, Papulosquamous, Connective Tissue and Alopecia Kathleen Haycraft, DNP, FNP/PNP-BC, DCNP, FAANP Objectives

    Blistering, Papulosquamous, Connective Tissue and Alopecia Kathleen Haycraft, DNP, FNP/PNP-BC, DCNP, FAANP Objectives • Identify examples of papulosquamous disease and state treatment options • Identify examples of connective tissue disease and state treatment options • Identify examples of blistering diseases and state treatment options • Identify examples of alopecia and state treatment options Papulosquamous Psoriasis • Latin means “itchy plaque”. • In truth it is less itchy than yeast and eczema • Variable • Painful in high friction spots Psoriasis Plaque ©kathleenhaycraft Psoriasis ©kathleen haycraft ©kathleenhaycraft The clue to the vaginal pic ©kathleenhaycraft ©kathleenhaycraft Plantar Psoriasis ©kathleenhaycraft Palmar Psoriasis ©kathleenhaycraft Nivolumab induced Psoriasis ©[email protected] Psoriasis and its many forms • Plaque..85% • Scalp • Palmoplantar • Guttate • Inverse • Erythrodermic • Psoriatic arthritis • Psoriatic nails Cause • Affects 2 to 5% of the population • Many mediators including the T cell lymphocyte. • Many chemicals downstream including TNF alpha, PDE, Il 12, 23, 17 as well as a variety of inflammatory cytokines • These chemicals are distributed throughout the body • Imbalance between pro inflammatory and anti-inflammatory chemicals • Can be triggered by strep, HIV, Hepatitis, and a wide variety of infectious organisms Psoriasis causes • Koebner phenomenon after surgery or trauma • Drugs such as beta blockers, lithium, antimalarials • The cytokines result in proliferation of keratinocytes and angiogenesis (resulting in the Auspitz sign) • May be mild to severe and location of scalp, genitalia, face may trump degree of psoriasis (BSA- Comorbidities • Reviewed in the cutaneous manifestations of systemic disease • Range from depression to MI, psoriatic arthritis, malignancy, Dm • Future treatments may be based on how they treat the comorbids • Diagnose with visual or biopsy Treatment • Topical corticosteroids..caution to not over use particularly in high risk areas.
  • History of Psoriasis and Parapsoriasis

    History of Psoriasis and Parapsoriasis

    History of Psoriasis and Parapsoriasis By Karl Holubar Summary Parapsoriasis is «oï a disease entity. Jt is an auxiliary term introduced in J 902 to group several dermatoses w>itk a/aint similarity to psoriasis. Tlie liistorical development leading to tlie creation o/ t/ie term parapsoriasis is outlined and t/te Itistory o/psoriasis is 6rie/ly reviewed. Semantic and terminological considerations Obviously, para-psoriasis as a term has been created in analogy to psoriasis. We should remember similar neologisms in medical language, e. g. protein and para-protein; typhoid and para-typhoid, thyroid and para-thyroid, phimosis and para-phimosis, eventually, pemphigus and para-pemphigus (the latter in 1955 this term was to be employed instead of pemphigoid but was not accepted by the dermatological world). Literally, para is a Greek preposition, (with the genitive, dative and accusative), meaning: by the side of, next to something, alongside something. In medicine, para is used often as a prefix to another term, which designates a condition somewhat similar to the one under consideration. The same holds for psoriasis and parapsoria- sis. In detail, though, it is a bit more complicated. Parapsoriasis has more than one "/at/ier", three in fact: ideiurick /Iu.spitz f 1835—1886,), Paul Gerson Luna (A850—1929j and Louis Procç fI856—I928J. Auspitz, in 1881, had published a new system of skin diseases the seventh class of which was called epidermidoses, subdivided into liypcrlcfiratose.s, parakeratoses, kerato/y- ses, the characteristics of which were excessive keratinization, abnormal keratinization and insufficent keratinization. When Unna, in 1890®, pub- lished his two reports on what he called parakeratosis variegata, he referred to Auspitz' system and term when coining his own.
  • Dermatological Indications of Disease - Part II This Patient on Dialysis Is Showing: A

    Dermatological Indications of Disease - Part II This Patient on Dialysis Is Showing: A

    “Cutaneous Manifestations of Disease” ACOI - Las Vegas FR Darrow, DO, MACOI Burrell College of Osteopathic Medicine This 56 year old man has a history of headaches, jaw claudication and recent onset of blindness in his left eye. Sed rate is 110. He has: A. Ergot poisoning. B. Cholesterol emboli. C. Temporal arteritis. D. Scleroderma. E. Mucormycosis. Varicella associated. GCA complex = Cranial arteritis; Aortic arch syndrome; Fever/wasting syndrome (FUO); Polymyalgia rheumatica. This patient missed his vaccine due at age: A. 45 B. 50 C. 55 D. 60 E. 65 He must see a (an): A. neurologist. B. opthalmologist. C. cardiologist. D. gastroenterologist. E. surgeon. Medscape This 60 y/o male patient would most likely have which of the following as a pathogen? A. Pseudomonas B. Group B streptococcus* C. Listeria D. Pneumococcus E. Staphylococcus epidermidis This skin condition, erysipelas, may rarely lead to septicemia, thrombophlebitis, septic arthritis, osteomyelitis, and endocarditis. Involves the lymphatics with scarring and chronic lymphedema. *more likely pyogenes/beta hemolytic Streptococcus This patient is susceptible to: A. psoriasis. B. rheumatic fever. C. vasculitis. D. Celiac disease E. membranoproliferative glomerulonephritis. Also susceptible to PSGN and scarlet fever and reactive arthritis. Culture if MRSA suspected. This patient has antithyroid antibodies. This is: • A. alopecia areata. • B. psoriasis. • C. tinea. • D. lichen planus. • E. syphilis. Search for Hashimoto’s or Addison’s or other B8, Q2, Q3, DRB1, DR3, DR4, DR8 diseases. This patient who works in the electronics industry presents with paresthesias, abdominal pain, fingernail changes, and the below findings. He may well have poisoning from : A. lead. B.
  • Differential Diagnosis in Dermatology

    Differential Diagnosis in Dermatology

    Differential Diagnosis in Dermatology ZohrehTehranchi Dermatologist COMMON ACNE AND CYSTIC ACNE Rosacea Rosacea PERIORAL DERMATITIS ECZEMA/DERMATITIS Chronic irritant dermatitis Dyshidrotic eczematous dermatitis Childood atopic dermatitis Autosensitization dermatitis (“id” reaction): dermatophytid Seborrheic dermatitis PSORIASIS VULGARIS Pemphigus vulgaris BULLOUS PEMPHIGOID (BP) Pityriasis rosea small-plaque parapsoriasis Large-plaque parapsoriasis (parapsoriasis en plaques) LICHEN PLANUS (LP) GRANULOMA ANNULARE (GA) Erythema multiforme ERYTHEMA NODOSUM Actinic keratoses Bowen disease (Squamous cell carcinoma in situ) Bowen disease and invasive SCC Squamous cell carcinoma: invasive on the lip Squamous cell carcinoma, well differentiated Squamous cell carcinoma, undifferentiated Squamous cell carcinoma, advanced, well differentiated, on the hand Keratoacanthoma showing different stages of evolution BASAL CELL CARCINOMA (BCC) Basal cell carcinoma, ulcerated: Rodent ulcer A large rodent ulcer in the nuchal and Bas cell calarcinoma: sclerosing type retroauricular area extending to the temple Basal cell carcinoma, sclerosing, nodular, Superficial basal cell carcinoma: solitary lesion and multiple lesions Superficial basal cell carcinoma, invasive Basal cell carcinoma, pigmented Dysplastic nevi Superficial spreading melanoma: arising within a dysplastic nevus Congenital nevomelanocytic nevus Melanoma: arising in small CNMN Melanoma in situ: lentigo maligna Melanoma in situ, superficial spreading type Superficial spreading melanoma, vertical
  • Versus Arthritis Vasculitis Information Booklet

    Versus Arthritis Vasculitis Information Booklet

    Condition Vasculitis Vasculitis This booklet provides information and answers to your questions about this condition. Arthritis Research UK booklets are produced and printed entirely from charitable donations. What is vasculitis? Vasculitis means inflammation of the blood vessels. There are several different types of the condition, many with unknown causes, but treatments can be very effective. In this booklet we’ll briefly explain the main types of vasculitis, how they’re diagnosed and treated, what you can do to help yourself and where to get more information. At the back of this booklet you’ll find a brief glossary of medical words – we’ve underlined these when they’re first used. www.arthritisresearchuk.org Page 2 of 32 Vasculitis information booklet Arthritis Research UK What’s inside? 2 Vasculitis at a glance 5 Who diagnoses and treats 15 What is the outlook? vasculitis? 15 How is vasculitis diagnosed? 6 What is vasculitis? – What tests are there? 8 What are the symptoms 17 What treatments are there for vasculitis? of vasculitis? – Drugs 9 What types of vasculitis 20 Self-help and daily living are there? – Exercise – Takayasu arteritis (TA) – Diet and nutrition – Giant cell arteritis (temporal arteritis) – Stop smoking – Polyarteritis nodosa (PAN) – Keep warm – Kawasaki disease 22 Research and new – Granulomatosis with polyangiitis developments (Wegener’s granulomatosis) 23 Glossary – Behçet’s syndrome – Eosinophilic granulomatosis 26 Where can I find out more? with polyangiitis (Churg–Strauss 28 We’re here to help syndrome) – Microscopic polyangiitis – Cryoglobulin-associated vasculitis – Immunoglobulin A vasculitis (Henoch–Schönlein purpura) 14 Who gets vasculitis? 15 What causes vasculitis? Page 3 of 32 Vasculitis information booklet At a glance Vasculitis There are several different types of vasculitis but all are treatable.
  • Papular Pityriasis Rosea

    Papular Pityriasis Rosea

    Continuing Medical Education Papular Pityriasis Rosea 2nd Lt Ronald M. Bernardin, MSC, USAF; Maj Steven E. Ritter, MC, FS, USAF; Lt Col Michael R. Murchland, MC, FS, USAF GOAL To describe a case of papular pityriasis rosea (PR) OBJECTIVES Upon completion of this activity, dermatologists and general practitioners should be able to: 1. Outline the varying clinical presentations of PR. 2. Discuss the theoretical etiologies of PR. 3. Describe therapy for PR. CME Test on page 48. This article has been peer reviewed and Medicine is accredited by the ACCME to provide approved by Michael Fisher, MD, Professor of continuing medical education for physicians. Medicine, Albert Einstein College of Medicine. Albert Einstein College of Medicine designates Review date: June 2002. this educational activity for a maximum of 1.0 hour This activity has been planned and implemented in category 1 credit toward the AMA Physician’s in accordance with the Essential Areas and Policies Recognition Award. Each physician should claim of the Accreditation Council for Continuing Medical only those hours of credit that he/she actually spent Education through the joint sponsorship of Albert in the educational activity. Einstein College of Medicine and Quadrant This activity has been planned and produced in HealthCom, Inc. The Albert Einstein College of accordance with ACCME Essentials. Pityriasis rosea (PR) is a seasonal papulosqua- and treatment options. Papular PR is atypical, pre- mous disorder that can be easily confused with a senting in a minority of patients, and may pose a wide variety of similar appearing cutaneous disor- diagnostic challenge. Being familiar with these ders.
  • Immune-Mediated Diseases in a Nutshell

    Immune-Mediated Diseases in a Nutshell

    Immune-Mediated Diseases In a Nutshell Objectives Describe the epidemiology, clinical presentation, pathogenesis and pathologic changes of autoimmune diseases, including lupus erythematosis, rheumatoid arthritis, vasculitis, temporal arteritis and Wegener's granulomatosis Systemic Lupus Erythematosus Systemic lupus erythematosus: clinical features Febrile, multisystem inflammatory disease Variably affects wide range of organs and tissues, especially skin, kidneys, serosal surfaces, joints, heart Clinical course highly variable, often with multiple exacerbations and remissions Especially prevalent in young women, black Americans Prevalence: up to 1 to 2,500 persons Systemic lupus erythematosus: pathogenesis Autoantibodies develop against a variety of antigens: Nucleoproteins / nucleic acids DNA histones nonhistone RNA-binding proteins Blood cells erythrocytes platelets lymphocytes Phospholipids (e.g., “lupus anticoagulant”) Systemic lupus erythematosus: pathogenesis Antigen-antibody Antibody bound to immune complexes cells leads to lysis form via complement- mediated Complexes deposit in cytotoxicity or numerous sites, ADCC initiate complement cascade, and trigger inflammation Type III Hypersensitivity Type II Hypersensitivity Systemic lupus erythematosus: pathogenesis Possible causes of autoantibody production Intrinsic B cell defect Excessive helper T cell activity Deficient suppressor T cell activity Rheumatoid Arthritis Rheumatoid arthritis: clinical features Systemic, chronic inflammatory disease Principally affects joints: severe,